Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Fast-growings companies in Nicotinamide mononucleotide
by Most Patent Filing In 3 Years in the China in 2022

The Nicotinamide mononucleotide top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 3 Years Nicotinamide mononucleotide Fast-growings in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
#
Company Name
Region
Tech Topics
Total
1
Patent: 3
2
Nutrition,Health care,Arachidonic acid,
...[+2]
Patent: 3
3
Western culture,TUTOR,Silicon carbide,
...[+2]
Patent: 3
4
Patent: 3
5
Medicine,Bead,Cardiovascular agent,
...[+2]
Patent: 3
6
Patent: 2
7
Patent: 2
8
Zhongke Health Industry Group Corp., Ltd
Patent: 2
9
Patent: 2
10
Health care,Genetic engineering,Enzyme,
...[+2]
Patent: 2
11
Patent: 2
12
Patent: 2
13
Patent: 2
14
Nanjing Tech University
Patent: 2
15
Academic Training,Educational institution,Graduate degree,
...[+2]
Patent: 1
16
Patent: 1
17
Patent: 1
18
Pinyin,Public university,Chemistry,
...[+2]
Patent: 1
19
Patent: 1
20
Patent: 1
Page generation time: Jun 20 2025